Increased cancer cell proliferation in prostate cancer patients with high levels of serum folate
- 9 February 2011
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 71 (12), 1287-1293
- https://doi.org/10.1002/pros.21346
Abstract
BACKGROUND A recent clinical trial revealed that folic acid supplementation is associated with an increased incidence of prostate cancer (Figueiredo et al., J Natl Cancer Inst 2009; 101(6): 432–435). As tumor cells in culture proliferate directly in response to available folic acid, the goal of our study was to determine if there is a similar relationship between patient folate status, and the proliferative capacity of tumors in men with prostate cancer. METHODS Serum folate and/or prostate tissue folate was determined in 87 randomly selected patients undergoing surgery for prostate cancer, and compared to tumor proliferation in a subset. RESULTS Fasting serum folate levels were positively correlated with prostate tumor tissue folate content (n = 15; r = 0.577, P < 0.03). Mean serum folate was 62.6 nM (7.5–145.2 nM), 39.5% of patients used supplements containing folic acid (n = 86). The top quartile of patients had serum folates above 82 nM, six times the level considered adequate. Of these, 48% reported no supplement use. Among 50 patients with Gleason 7 disease, the mean proliferation index as determined by Ki67 staining was 6.17 ± 3.2% and 0.86 ± 0.92% in the tumors from patients in the highest (117 ± 15 nM) and lowest (18 ± 9 nM) quintiles for serum folate, respectively (P < 0.0001). CONCLUSIONS Increased cancer cell proliferation in men with higher serum folate concentrations is consistent with an increase in prostate cancer incidence observed with folate supplementation. Unexpectedly, more than 25% of patients had serum folate levels greater than sixfold adequate. Nearly half of these men reported no supplement use, suggesting either altered folate metabolism and/or sustained consumption of folic acid from fortified foods. Prostate 71:1287–1293, 2011.Keywords
Funding Information
- DOD PCRP (W81XWH-07-1-0146)
- NIH (R21 CA124892, R01CA138444, P20CA103730, P30CA047904)
- American Institute for Cancer Research
- U.S. Department of Agriculture (581950-9-001)
This publication has 32 references indexed in Scilit:
- Associations of Folate, Vitamin B12, Homocysteine, and Folate-Pathway Polymorphisms with Prostate-Specific Antigen Velocity in Men with Localized Prostate CancerCancer Epidemiology, Biomarkers & Prevention, 2010
- Plasma Folate Concentrations Are Positively Associated with Risk of Estrogen Receptor β Negative Breast Cancer in a Swedish Nested Case Control Study ,Journal of Nutrition, 2010
- Unmetabolized serum folic acid and its relation to folic acid intake from diet and supplements in a nationally representative sample of adults aged ≥60 y in the United StatesThe American Journal of Clinical Nutrition, 2010
- Expression of prostate‐specific membrane antigen (PSMA), increases cell folate uptake and proliferation and suggests a novel role for PSMA in the uptake of the non‐polyglutamated folate, folic acidThe Prostate, 2009
- Serum Creatinine and Prostate Cancer Risk in a Prospective StudyCancer Epidemiology, Biomarkers & Prevention, 2009
- Folate, cancer risk, and the Greek god, Proteus: a tale of two chameleonsPublished by Oxford University Press (OUP) ,2009
- Folic Acid and Risk of Prostate Cancer: Results From a Randomized Clinical TrialJNCI Journal of the National Cancer Institute, 2009
- Moderate Expression of Prostate-Specific Membrane Antigen, a Tissue Differentiation Antigen and Folate Hydrolase, Facilitates Prostate CarcinogenesisCancer Research, 2008
- Folate: a magic bullet or a double edged sword for colorectal cancer prevention?Gut, 2006
- Immunohistochemical Expression of Ki-67 Antigen, Cox-2 and Bax/Bcl-2 in Prostate Cancer; Prognostic Value in Biopsies and Radical Prostatectomy SpecimensEuropean Urology, 2005